| Disease Name |
Multiple Sclerosis, Relapsing-Remitting |
| Nocoding RNA Name |
hsa-miR-17 |
| Expression Pattern |
up-regulated |
| Species |
Homo sapiens |
| Detection Methods |
Quantitative Real-time RT-PCR etc. |
| Target |
p21 |
| Tissue |
blood(Peripheral blood mononuclear cells) |
| Treatment |
N/A
|
| PubMed ID |
24901013 |
| Year |
2014 |
| Detail Description |
we validated upregulation of miR-17 expression in RRMS patients,Interestingly, natalizumab treatment decreased miR-17 expression in MS patients,Downregulation of miR-17 was associated with upregulation of PTEN, BIM, E2F1, and p21 target genes,confirmin vitrothe link between miR-17 and TGFBR2 expressions. |
|